Logo image of EXA.PA

EXAIL TECHNOLOGIES (EXA.PA) Stock Fundamental Analysis

Europe - EPA:EXA - FR0000062671 - Common Stock

76 EUR
-5.2 (-6.4%)
Last: 11/21/2025, 7:00:00 PM
Fundamental Rating

3

EXA gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 44 industry peers in the Aerospace & Defense industry. EXA has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, EXA is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

EXA had negative earnings in the past year.
In the past year EXA had a positive cash flow from operations.
In multiple years EXA reported negative net income over the last 5 years.
EXA had a positive operating cash flow in 4 of the past 5 years.
EXA.PA Yearly Net Income VS EBIT VS OCF VS FCFEXA.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M 80M

1.2 Ratios

EXA has a Return On Assets of -0.44%. This is amonst the worse of the industry: EXA underperforms 81.82% of its industry peers.
EXA's Return On Equity of -3.04% is on the low side compared to the rest of the industry. EXA is outperformed by 81.82% of its industry peers.
EXA has a worse Return On Invested Capital (2.85%) than 72.73% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for EXA is significantly below the industry average of 9.16%.
The 3 year average ROIC (2.19%) for EXA is below the current ROIC(2.85%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -0.44%
ROE -3.04%
ROIC 2.85%
ROA(3y)0.31%
ROA(5y)2.54%
ROE(3y)1.41%
ROE(5y)15.21%
ROIC(3y)2.19%
ROIC(5y)2.9%
EXA.PA Yearly ROA, ROE, ROICEXA.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

1.3 Margins

EXA has a worse Operating Margin (6.05%) than 65.91% of its industry peers.
EXA's Operating Margin has improved in the last couple of years.
EXA has a Gross Margin of 55.36%. This is in the better half of the industry: EXA outperforms 79.55% of its industry peers.
EXA's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 6.05%
PM (TTM) N/A
GM 55.36%
OM growth 3Y-17.32%
OM growth 5Y16.02%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.59%
GM growth 5Y2.77%
EXA.PA Yearly Profit, Operating, Gross MarginsEXA.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so EXA is destroying value.
EXA has less shares outstanding than it did 1 year ago.
The number of shares outstanding for EXA has been increased compared to 5 years ago.
EXA has a worse debt/assets ratio than last year.
EXA.PA Yearly Shares OutstandingEXA.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
EXA.PA Yearly Total Debt VS Total AssetsEXA.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

An Altman-Z score of 1.98 indicates that EXA is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 1.98, EXA is doing worse than 63.64% of the companies in the same industry.
The Debt to FCF ratio of EXA is 6.15, which is on the high side as it means it would take EXA, 6.15 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of EXA (6.15) is comparable to the rest of the industry.
EXA has a Debt/Equity ratio of 2.52. This is a high value indicating a heavy dependency on external financing.
EXA has a worse Debt to Equity ratio (2.52) than 84.09% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.52
Debt/FCF 6.15
Altman-Z 1.98
ROIC/WACC0.37
WACC7.71%
EXA.PA Yearly LT Debt VS Equity VS FCFEXA.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 1.25 indicates that EXA should not have too much problems paying its short term obligations.
The Current ratio of EXA (1.25) is better than 63.64% of its industry peers.
A Quick Ratio of 0.93 indicates that EXA may have some problems paying its short term obligations.
EXA has a better Quick ratio (0.93) than 65.91% of its industry peers.
Industry RankSector Rank
Current Ratio 1.25
Quick Ratio 0.93
EXA.PA Yearly Current Assets VS Current LiabilitesEXA.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

5

3. Growth

3.1 Past

The earnings per share for EXA have decreased strongly by -128.05% in the last year.
The Revenue has grown by 15.32% in the past year. This is quite good.
EXA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.32% yearly.
EPS 1Y (TTM)-128.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100.66%
Revenue 1Y (TTM)15.32%
Revenue growth 3Y47.65%
Revenue growth 5Y6.32%
Sales Q2Q%24.34%

3.2 Future

Based on estimates for the next years, EXA will show a very strong growth in Earnings Per Share. The EPS will grow by 158.46% on average per year.
Based on estimates for the next years, EXA will show a quite strong growth in Revenue. The Revenue will grow by 19.03% on average per year.
EPS Next Y1210.6%
EPS Next 2Y465.47%
EPS Next 3Y279.57%
EPS Next 5Y158.46%
Revenue Next Year24.34%
Revenue Next 2Y24.39%
Revenue Next 3Y23.82%
Revenue Next 5Y19.03%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
EXA.PA Yearly Revenue VS EstimatesEXA.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M
EXA.PA Yearly EPS VS EstimatesEXA.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 4 6 8

3

4. Valuation

4.1 Price/Earnings Ratio

EXA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 90.66, the valuation of EXA can be described as expensive.
Based on the Price/Forward Earnings ratio, EXA is valued a bit more expensive than 79.55% of the companies in the same industry.
EXA is valuated expensively when we compare the Price/Forward Earnings ratio to 34.46, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 90.66
EXA.PA Price Earnings VS Forward Price EarningsEXA.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200 -300

4.2 Price Multiples

72.73% of the companies in the same industry are more expensive than EXA, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 23.35
EV/EBITDA N/A
EXA.PA Per share dataEXA.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
EXA's earnings are expected to grow with 279.57% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y465.47%
EPS Next 3Y279.57%

0

5. Dividend

5.1 Amount

No dividends for EXA!.
Industry RankSector Rank
Dividend Yield N/A

EXAIL TECHNOLOGIES

EPA:EXA (11/21/2025, 7:00:00 PM)

76

-5.2 (-6.4%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)10-22 2025-10-22
Earnings (Next)03-23 2026-03-23/amc
Inst Owners16.83%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.32B
Revenue(TTM)373.06M
Net Income(TTM)-3.64M
Analysts82.22
Price Target109.65 (44.28%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.02
Dividend Growth(5Y)-41.67%
DP-10.05%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)32.72%
PT rev (3m)15.16%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)4.53%
EPS NY rev (3m)-4.82%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.17%
Revenue NY rev (3m)1.91%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 90.66
P/S 3.55
P/FCF 23.35
P/OCF 14.48
P/B 11.04
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.21
EYN/A
EPS(NY)0.84
Fwd EY1.1%
FCF(TTM)3.25
FCFY4.28%
OCF(TTM)5.25
OCFY6.9%
SpS21.42
BVpS6.88
TBVpS-17.04
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.44%
ROE -3.04%
ROCE 3.88%
ROIC 2.85%
ROICexc 3.14%
ROICexgc 14.88%
OM 6.05%
PM (TTM) N/A
GM 55.36%
FCFM 15.2%
ROA(3y)0.31%
ROA(5y)2.54%
ROE(3y)1.41%
ROE(5y)15.21%
ROIC(3y)2.19%
ROIC(5y)2.9%
ROICexc(3y)2.4%
ROICexc(5y)3.68%
ROICexgc(3y)9.45%
ROICexgc(5y)12.41%
ROCE(3y)2.98%
ROCE(5y)3.95%
ROICexgc growth 3Y18.91%
ROICexgc growth 5Y18.06%
ROICexc growth 3Y-17.84%
ROICexc growth 5Y1.29%
OM growth 3Y-17.32%
OM growth 5Y16.02%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.59%
GM growth 5Y2.77%
F-Score5
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 2.52
Debt/FCF 6.15
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 9.3%
Interest Coverage 1.55
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.25
Quick Ratio 0.93
Altman-Z 1.98
F-Score5
WACC7.71%
ROIC/WACC0.37
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)9.56%
Cap/Sales(5y)12.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-128.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100.66%
EPS Next Y1210.6%
EPS Next 2Y465.47%
EPS Next 3Y279.57%
EPS Next 5Y158.46%
Revenue 1Y (TTM)15.32%
Revenue growth 3Y47.65%
Revenue growth 5Y6.32%
Sales Q2Q%24.34%
Revenue Next Year24.34%
Revenue Next 2Y24.39%
Revenue Next 3Y23.82%
Revenue Next 5Y19.03%
EBIT growth 1Y1338.9%
EBIT growth 3Y22.08%
EBIT growth 5Y23.35%
EBIT Next Year180.81%
EBIT Next 3Y69.73%
EBIT Next 5Y47.2%
FCF growth 1Y137.85%
FCF growth 3YN/A
FCF growth 5Y40.49%
OCF growth 1Y64.25%
OCF growth 3YN/A
OCF growth 5Y26.69%

EXAIL TECHNOLOGIES / EXA.PA FAQ

What is the fundamental rating for EXA stock?

ChartMill assigns a fundamental rating of 3 / 10 to EXA.PA.


Can you provide the valuation status for EXAIL TECHNOLOGIES?

ChartMill assigns a valuation rating of 3 / 10 to EXAIL TECHNOLOGIES (EXA.PA). This can be considered as Overvalued.


Can you provide the profitability details for EXAIL TECHNOLOGIES?

EXAIL TECHNOLOGIES (EXA.PA) has a profitability rating of 3 / 10.


What is the earnings growth outlook for EXAIL TECHNOLOGIES?

The Earnings per Share (EPS) of EXAIL TECHNOLOGIES (EXA.PA) is expected to grow by 1210.6% in the next year.